Prophylactic pretransplant ganciclovir to reduce cytomegalovirus infection after hematopoietic stem cell transplantation

Autor: Reed, Daniel R., Petroni, Gina R., West, Melissa, Jones, Caroline, Alfaraj, Abeer, Williams, Paige G., DeGregory, Kathlene, Grose, Kyle, Monson, Sandra, Varadarajan, Indumathy, Volodin, Leonid, Donowitz, Gerald R., Kindwall-Keller, Tamila L., Ballen, Karen K.

Publikováno v: In Hematology/Oncology and Stem Cell Therapy May 2021

Absolute Lymphocyte Count (ALC) Recovery in Multiple Myeloma (MM) Patients after Autologous Stem Cell Transplant (ASCT) Is Related to CD34+ Dose-Infused

Autor: Foster, Laahn H., Williams, Paige G., Petroni, Gina, Horton, Bethany J., Kindwall-Keller, Tamila L.

Publikováno v: In Biology of Blood and Marrow Transplantation February 2015 21(2) Supplement:S135-S135

Outcomes of Double Unit Umbilical Cord Blood Transplantation Using Fludarabine/Busulfan Based Reduced Intensity Conditioning Regimen

Autor: Volodin, Leonid, Beitinjaneh, Amer, Salman, Huda, Laughlin, Mary J., Smolkin, Mark, Spencer, Hannah E., Lee, Carlos G., Williams, Paige G., DeGregory, Kathlene, Kindwall-Keller, Tamila L.

Publikováno v: In Biology of Blood and Marrow Transplantation February 2014 20(2) Supplement:S142-S142

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

Prophylactic Pretransplant Ganciclovir to Reduce Cytomegalovirus Infection After Hematopoietic Stem Cell Transplantation.

Autor: Reed DR; Section of Hematology and Oncology, Comprehensive Cancer Center of Wake Forest Baptist Health, Winston-Salem, NC, USA., Petroni GR; Department of Public Health Sciences, University of Virginia, Charlottesville, VA, USA., West M; Department of Pharmacy, University of Virginia, Charlottesville, VA, USA., Jones C; Department of Pharmacy, University of Virginia, Charlottesville, VA, USA., Alfaraj A; BayHealth Hematology/Oncology Associates, Delaware, PA, USA., Williams PG; Division of Hematology and Oncology, University of Virginia, Charlottesville, VA, USA., DeGregory K; Department of Pharmacy, University of Virginia, Charlottesville, VA, USA., Grose K; Department of Pharmacy, University of Kansas, Kansas City, KS, USA., Monson S; Department of Public Health Sciences, University of Virginia, Charlottesville, VA, USA., Varadarajan I; Division of Hematology and Oncology, University of Virginia, Charlottesville, VA, USA., Volodin L; Division of Hematology and Oncology, University of Virginia, Charlottesville, VA, USA., Donowitz GR; Department of Infectious Disease, University of Virginia, Charlottesville, VA, USA., Kindwall-Keller TL; Division of Hematology and Oncology, University of Virginia, Charlottesville, VA, USA., Ballen KK; Division of Hematology and Oncology, University of Virginia, Charlottesville, VA, USA.

Publikováno v: Hematology/oncology and stem cell therapy [Hematol Oncol Stem Cell Ther] 2023 Jan 12; Vol. 16 (1), pp. 61-69. Date of Electronic Publication: 2023 Jan 12.